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Microbiome—Marching toward Function
At a broad, simplistic level, most of us think of microbes as the ‘‘bad guys,’’ and the current worldwide Ebola outbreak does not help
this perspective. However, there have been hints of partnerships between humans and microbes for centuries. A number of exciting
studies have started to unveil the interplay between mammalian and microbial cells in metabolic health, immunity, gut function,
colorectal cancer, and even behavior, to name a few. It is humbling to think that microbial cells outnumber human cells by a factor
of ten to one and that each of us carries a hundred times as many microbial as human genes. But make no mistake: microbes are
not just along for the ride, they are active participants in both their own and their host’s health and an (epi)genetic force to be reck-
oned with. The microbiome is quite likely one of the main determinants of interindividual variability, and understanding human-mi-
crobiome intersections will not only aid in bettering human health globally but also help propel personalized medicine and nutrition
forward.
The microbiome is a popular topic with scientists and laypeople alike. Recently, there have been a number of excellent reviews
highlighting the diverse involvement of the microbiome and, importantly, some of the challenges facing investigators in this nascent
field. The role of microbes in metabolic disease, including diabetes and obesity, is relatively well established as the microbes have
been found ‘‘guilty by association’’ and the transfer of diseased microbiota into germ-free mice recapitulates metabolic dysfunc-
tion. The converse applies as ‘‘healthy’’ microbiota transplants can reverse obesity symptoms. As we move forward, the next stage
is in furthering our understanding of microbiome function and mechanism. The seven perspectives included in this Special Issue of
Cell Metabolism focus on the identification and characterization of the bioactive components driving the complex metabolic
ecosystem of human-microbe relationships. The articles are not meant to be a comprehensive overview of the field, but rather
to present a number of viewpoints that should provide solid food for thought for further integration of the microbiome in metabolic
research.
The first Perspective, by Mazmanian and colleagues, highlights microbial-derived metabolites as mediators of the micro-
biome’s effects on the host. Besides ‘‘primary metabolites,’’ encoded by the bacterial metagenome, the conversion of small
molecules into secondary metabolites, ‘‘specialized metabolites,’’ could help explain many of the gut microbiota’s effects on
host health.
Next, Huttenhower and colleagues discuss computational methods, including prediction based on evolutionary relationships and
gene network context, to experimentally validate the function of bioactive microbial products. The authors also emphasize the need
for information integration across meta-omics platforms and studies.
In a similar vein, Borenstein and colleagues tackle, at a systems level, how microbial community members are a whole village in
themselves, splitting metabolic processes and interacting with each other and the host. They highlight computational modeling to
start deconvolving the microbiome metagenome and to infer and study metabolic interactions among different species. One of their
quotes from Weaver, 1948, captures the intricacies of this ecosystem well: ‘‘Complexity, especially in biology, is a product not sim-
ply of the number of parts a system is composed of, but rather of the complex and often nonlinear way in which these parts
interact.’’
Exploring the connection between the gut microbiota and metabolic diseases, such as diabetes, Ba¨ckhed and colleagues posit
that, while changes in the gut microbiota could be causal for diabetes, the disease itself may alter the microbiota. Recent findings
highlight that antidiabetic treatments, such as the drug metformin or bariatric surgery, are linked to reshaping of the gut microbiota.
The authors put forward the idea of harnessing the microbiome for predictive identification of subclinical diabetes and delve into the
mechanistic players derived from the interactions between the microbiome and diet, which could pave the way to novel microbiome-
derived therapies for diabetes.
Patterson and Turnbaugh, in turn, discuss how the human microbiome is likely an important contributor of interindividual vari-
ability in the xenobiotic response, which is further complicated by the dynamic and plastic nature of the human microbiota.
They highlight a few examples of the gut microbiome modulating the metabolic effects of drugs in humans such as response
to the HMG-CoA reductase inhibitor simvastatin, the antipsychotic olanzapine, and metformin. They speculate on the underlying
‘‘reasons’’ for the involvement of gut microbiota enzymes in xenobiotics and highlight the possibility of horizontal gene transfer.
Patterson and Turnbaugh contend that applying the fundamentals of toxicology to microbiology would greatly help accelerate
personalized medicine.
Microbes can help provide essential vitamins to a number of animal hosts. However, Goodman and colleagues argue that, in the
case of vitamin B12, human gut microbial communities are actually competitors for dietary vitamin B12 and related corrinoid cofac-
tors. While both human andmicrobial cells use corrinoids as enzyme cofactors, microbes have additional extensive use of these fac-
tors for gene expression. Interestingly, Goodman and colleagues propose that targeted manipulations of cobalamin and corrinoids
could be harnessed to actively shape the composition of human gut microbial ecosystems.
We close this series with a broader discussion of what fuels the microbiota. Erica and Justin Sonnenburg debate the
concept of gut microbiota (im)balance in industrialized societies compared to more traditionalized ones and to what extent
the carbohydrate fuel source of the microbiota affects this ecosystem. They coin the concept of ‘‘microbiota-accessibleCell Metabolism 20, November 4, 2014 ª2014 Elsevier Inc. 697
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Editorialcarbohydrate’’ (MAC). Availability of metabolic MACs may affect not only microbiota composition and biodiversity, but also meta-
bolic output.
We hope you enjoy reading this Special Issue asmuch as we have enjoyed putting it together. We look forward to the next steps of
unravelling the metabolic functionalities of the gut microbiome, the results of which we hope you will continue to find in the pages of
Cell Metabolism.Nikla Emambokus
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